Supply Chain

Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces

Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C&GT sectors

Tufts analysis uncovers various benefits to conducting decentralized clinical trials—including financial benefits

Will welcome seven temperature-controlled processing suites to accommodate various biologic drug needs

Partnership enhances CBM’s manufacturing capabilities in C&GT space

A prescription for making the pharma supply chain more resilient, reliable and disruption-proof

November report indicates a decrease in air cargo compared to October, but a rise in global demand compared to pre-Covid numbers

Syneos Health’s annual survey reveals the potential for shifts in the M&A space

Center’s 89,000 square-foot expansion expected to double its capacity

Strategic collaboration will feature Mammoth’s CRISPR know-how to design in vivo therapies

Development project features 150,000 square feet of additional space to accommodate company’s 3PL offerings

Ruling also shortens time required between the initial two shots and the booster to five months

The benefits of hybrid direct-to-patient studies and supply chain structures in boosting drug access, influencing clinical trial design

Emergency-use clearance of Pfizer drug a major milestone in the fight against the now-omicron-fueled virus in the US

Taking cues from launches so far in oncology and rheumatology, three important considerations for biosimilar marketability are outlined

The new parent company will expand security, monitoring and remedial action for pharma shipments

Parties will collaborate in enhancing chronic disease care therapies

Building a data-sharing system for the US Drug Supply Chain Security Act (DSCSA) is two years from a mandated completion—will industry be ready?

Firms will merge under the CSafe brand, allowing for delivery of temperature-sensitive items

ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs

Pharma firms—not only in Europe but in the US as well—are continuously looking for alternative supply channels inside their respective blocks

Deal expands pharma giant’s influence in inflammation and immunology markets

Includes 20 million more doses by the end of the 2021

The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space

Survey draws attention to the need for improving issues surrounding supply chain visibility

Site is located in the state of Gujarat, a major hub for pharma logistics

Collaboration focuses on continuing to improve time to therapy and medication adherence for patients, while effectively optimizing clinical data

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

Latest report indicates that air cargo demand is outperforming pre-Covid stats from 2019

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates